ARK Investment Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-64,286
| Closed | -$20.8M | – | 228 |
|
|
2020
Q2 | $20.8M | Sell |
64,286
-72,208
| -53% | -$23.4M | 0.22% | 60 |
|
|
2020
Q1 | $12.2M | Sell |
136,494
-245,587
| -64% | -$21.9M | 0.3% | 54 |
|
|
2019
Q4 | $15.1M | Buy |
382,081
+30,190
| +9% | +$1.2M | 0.38% | 44 |
|
|
2019
Q3 | $8.66M | Buy |
351,891
+22,306
| +7% | +$549K | 0.19% | 59 |
|
|
2019
Q2 | $11.6M | Buy |
329,585
+85,452
| +35% | +$3.01M | 0.29% | 48 |
|
|
2019
Q1 | $10.9M | Buy |
244,133
+86,996
| +55% | +$3.89M | 0.31% | 47 |
|
|
2018
Q4 | $7.54M | Sell |
157,137
-2,619
| -2% | -$126K | 0.31% | 50 |
|
|
2018
Q3 | $10.7M | Buy |
159,756
+60,201
| +60% | +$4.02M | 0.32% | 57 |
|
|
2018
Q2 | $4.68M | Buy |
99,555
+44,187
| +80% | +$2.08M | 0.17% | 65 |
|
|
2018
Q1 | $3.13M | Buy |
55,368
+31,512
| +132% | +$1.78M | 0.16% | 71 |
|
|
2017
Q4 | $1.18M | Buy |
23,856
+11,907
| +100% | +$590K | 0.09% | 89 |
|
|
2017
Q3 | $909K | Buy |
11,949
+6,457
| +118% | +$491K | 0.11% | 91 |
|
|
2017
Q2 | $517K | Buy |
5,492
+2,428
| +79% | +$229K | 0.1% | 81 |
|
|
2017
Q1 | $243K | Buy |
3,064
+462
| +18% | +$36.6K | 0.07% | 82 |
|
|
2016
Q4 | $217K | Buy |
+2,602
| New | +$217K | 0.08% | 76 |
|